This report is an updated version of the report published on the 24 April 2024 at 2:07 PM AEST.
Company Overview: Overview: Pro Medicus Limited (ASX: PME) is a health imaging IT provider that develops and supplies healthcare imaging software and services to hospitals, diagnostic imaging groups and other related health entities in Australia, Europe, and North America. Appen Limited (ASX: APX) is a technology company enabling organisations to launch artificial intelligence (AI) systems. The company has more than 25 years of experience in data sourcing, data annotation, and model evaluation. Its products and services aid governments as well as players in the technology, automotive, financial services, retail, and healthcare space. This Global Artificial Intelligence & Emerging Technologies Report covers the Company Overview & Price performance, Summary table, Key positives & negatives, Key metrics, Company details, technical guidance & Stock recommendation, and Price chart.
Section 1.0: Key Metrics in Pictures
Having looked at the key financial metrics above the below sections provide in-depth fundamental, and technical analysis on this Health Care Technology Business along with recommendation, technical support, and resistance level & indicative stop-loss.
Section 2.0: Pro Medicus Limited (‘Buy’ at AUD 108.130 current market price per share as on 24 April 2024)
2.1 Company Details
2.2 Valuation, Technical Summary & Stock Recommendation
The stock has increased by ~8.2% in last one month, and over the last three months, it has moved up by ~7.38%. The stock has a 52-week low and 52-week high of AUD 58.600 and AUD 111.885, respectively and is currently trading above the 52-week high-low average. PME was last covered in a report dated ’02 November 2022’.
Appen Limited (ASX: APX)
Section 3.0: Key Metrics in Pictures
Having looked at the key financial metrics above the below sections provide in-depth fundamental, and technical analysis on this Technology Stock along with recommendation, technical support, and resistance level & indicative stop-loss.
Section 4.0: Appen Limited (ASX: APX) (‘Speculative Buy’ at AUD 0.700 current market price per share as on 24 April 2024)
4.1 Company Details
4.2 Valuation, Technical Summary & Stock Recommendation
The stock has decreased by ~21% in last six months, and over the last nine months, it has moved down by ~65%. The stock has a 52-week low and 52-week high of AUD 0.260 and AUD 3.602, respectively and is currently trading below the 52-week high-low average. APX was last covered in a report dated ’18 March 2024’.
Markets are trading in a highly volatile zone currently due to certain macro-economic issues and geopolitical issues prevailing geopolitical tensions. Therefore, it is prudent to follow a cautious approach while investing.
Note 1: Past performance is neither an Indicator nor a guarantee of future performance.
Note 2: The reference date for all price data, currency, technical indicators, support, and resistance levels is 24 April 2024. The reference data in this report has been partly sourced from REFINITIV.
Note 3: Investment decisions should be made depending on an individual’s appetite for upside potential, risks, holding duration, and any previous holdings. An ‘Exit’ from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.
Note 4: Dividend Yield may vary as per the stock price movement.
Technical Indicators Defined: -
Support: A level at which the stock prices tend to find support if they are falling, and a downtrend may take a pause backed by demand or buying interest. Support 1 refers to the nearby support level for the stock and if the price breaches the level, then Support 2 may act as the crucial support level for the stock.
Resistance: A level at which the stock prices tend to find resistance when they are rising, and an uptrend may take a pause due to profit booking or selling interest. Resistance 1 refers to the nearby resistance level for the stock and if the price surpasses the level, then Resistance 2 may act as the crucial resistance level for the stock.
Stop-loss: It is a level to protect further losses in case of unfavourable movement in the stock prices.
Disclaimer-
This report has been issued by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and prepared by Kalkine and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine.
Any advice provided in this report is general advice only and does not take into account your objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your objectives, financial situation and needs before acting upon it.
There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine reports. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product.
You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice in this report or on the Kalkine website. Not all investments are appropriate for all people.
The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites. All information represents our views at the date of publication and may change without notice.
Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this report, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law, to the resupply of services. Please note past performance is neither an indicator nor a guarantee of future performance.
Please also read our Terms & Conditions and Financial Services Guide for further information.
Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this report or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.
Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website including entities covered in this Report.